MARKET

TLMD

Soc Telemed Inc
TLMD
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.5604
2.139
1.664
304,008,534.00
BRIEF-SOC Telemed Stockholders Approve Acquisition By Patient Square Capital
reuters.com · 04/04 20:39
SOC Telemed stockholders approve acquisition by Patient Square Capital
SOC Telemed (NASDAQ:TLMD) has announced that its stockholders approved the acquisition of SOC Telemed by Patient Square Capital, a leading dedicated health care investment firm, at a special meeting. Under
Seekingalpha · 04/04 20:33
SOC Telemed Shareholders Vote in Favor of $300 Million, Private-Equity Buyout Proposal
MT Newswires · 04/04 16:55
SOC Telemed Q4 Net Loss Narrows as Revenue Rises
MT Newswires · 03/31 04:46
SOC Telemed GAAP EPS of -$0.13, revenue of $27.98M
SOC Telemed press release (NASDAQ:TLMD): Q4 GAAP EPS of -$0.13. Revenue of $27.98M (+93.0% Y/Y).
Seekingalpha · 03/30 21:32
BRIEF-SOC Telemed Reports Fourth Quarter And Full Year 2021 Financial And Operating Results
reuters.com · 03/30 21:03
-- Earnings Flash (TLMD) SOC TELEMED Posts Q4 Revenue $28M, vs. Street Est of $26.1M
MT Newswires · 03/30 17:03
Analyst Ratings For SOC Telemed
SOC Telemed (NASDAQ:TLMD) has observed the following analyst ratings within the last quarter:
Benzinga · 02/07 17:15
More
No Data
Learn about the latest financial forecast of TLMD. Analyze the recent business situations of Soc Telemed Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

0.00%Strong Buy
0.00%Buy
100.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average TLMD stock price target is 3.000 with a high estimate of 3.000 and a low estimate of 3.000.
High3.000
Average3.000
Low3.000
Current 3.000
EPS
Actual
Estimate
-0.14-0.11-0.07-0.04
Q1 2021
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Institutional Holdings
Institutions: 93
Institutional Holdings: 67.67M
% Owned: 66.78%
Shares Outstanding: 101.34M
TypeInstitutionsShares
Increased
22
2.90M
New
21
753.16K
Decreased
21
2.82M
Sold Out
11
317.76K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Healthcare Facilities & Services
+1.33%
Healthcare Providers & Services
+0.47%
Key Executives
Non-Executive Chairman/Independent Director
Steven Shulman
Chief Executive Officer/Director
Christopher Gallagher
Non-Executive Vice Chairman/Independent Director
Joseph Greskoviak
Chief Financial Officer
David Fletcher
Chief Operating Officer
David Mikula
Chief Technology Officer
Sean Banerjee
General Counsel/Secretary
Eunice Kim
Other
R. Jason Hallock
Independent Director
Barbara Byrne
Independent Director
Thomas Carella
Independent Director
Gyasi Chisley
Independent Director
Amr Kronfol
Independent Director
Anne McGeorge
No Data
No Data

Webull offers kinds of Soc Telemed Inc stock information, including NASDAQ:TLMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TLMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TLMD stock methods without spending real money on the virtual paper trading platform.